Summit Therapeutics plc (SMMT)
After hours:
| Previous close | 3.5100 |
| Open | 3.5000 |
| Bid | 3.5000 x 200 |
| Ask | 3.5400 x 100 |
| Day's range | 3.3400 - 3.5500 |
| 52-week range | 1.3000 - 5.2200 |
| Volume | |
| Avg. volume | 2,302,846 |
| Market cap | 2.456B |
| Beta (5Y monthly) | -1.20 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.9900 |
| Earnings date | 09 May 2024 - 13 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 6.50 |
Business WireSummit Therapeutics Appoints Dr. Mostafa Ronaghi, Renowned Executive and Genomicist, to its Board of Directors
MIAMI, April 11, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that Mostafa Ronaghi, PhD, has been appointed to its Board of Directors, effective immediately.
Business WireSummit Therapeutics to Present at the Stifel 2024 Targeted Oncology Forum
MIAMI, April 10, 2024--Summit Therapeutics Inc. (NASDAQ: SMMT) ("Summit," "we," or the "Company") today announced that it will participate in and present at the Stifel 2024 Targeted Oncology Forum, which will be held virtually April 16-17, 2024. Dr. Maky Zanganeh, Chief Executive Officer and President, Robert W. Duggan, Chairman and Chief Executive Officer, Manmeet Soni, Chief Operating Officer & Chief Financial Officer, Dave Gancarz, Chief Business & Strategy Officer, and Dr. Allen S. Yang, Chi
Insider MonkeyInsiders Are Buying These 11 Penny Stocks
In this article, we will take a detailed look at Insiders Are Buying These 11 Penny Stocks. For a quick overview of such stocks, read our article Insiders Are Buying These 5 Penny Stocks. US stock market started the second quarter of 2024 in the red, driven by rising treasury yields, broader volatility and uncertainty around rate cuts […]
